Enliven Therapeutics, Inc.
Industry: Life Sciences ・ $ELVN on Nasdaq
Insider Sale
+$162,541
-1.94%
Shares
Shares Volume: 6,667 Shares
Average Share Price: $24.38
INSIDER
Patel Anish
CHIEF OPERATING OFFICER (Officer)
reported on Jan 10 2025
traded on Jan 7 2025
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 336,644 |
| PURCHASES/SALES 1Y | 0 / 13 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $222,029.48 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 2 |
| PURCHASES/SALES 1Y | 0 / 90 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $919,301.48 |
| COMPANY PREVIOUS TRADES |